Monthly Newsletter

Agilent Automation Solutions has announced that it has posted a recording webinar 'Solutions for Applying Automation to Next-Generation Sequencing Sample Prep' online to enable scientists who missed the event to review the presented information.

Located at http://event.on24.com/r.htm?e=210380&s=1&k=C2936186DABCC1615555937C04277D05 the webinar features viewpoints expressed by three experts in the field, who share examples from their laboratories on how to effectively adopt and utilize automation for NGS applications.

With presentations from the internationally renowned HudsonAlpha Institute of Biotechnology, Broad Institute of MIT & Harvard and Agilent Automation Solutions the webinar provides the audience with a comprehensive overview of the developments in Next Generation Sequencing (NGS) technologies, with an emphasis on the challenges that are routinely encountered at various stages in the sequencing and analysis of samples. It offers detailed information on the specific challenges associated with sample preparation and the benefits of using automation to alleviate some of the bottlenecks. Further information is provided on ways to increase and improve the sample throughput in sequencing and the application of automated NGS platforms in areas like cancer genetics, CNS research and targeted resequencing applications such as effective whole exon sequencing.

For further information on how Agilent Automation Solutions is enabling scientists involved with next generation sequencing to get better results faster please visit http://www.genomics.agilent.com/GenericA.aspx?PageType=Custom&SubPageType=Custom&PageID=2020.

From stand-alone units to fully integrated systems, Agilent Automation Solutions teams key sample preparation and creative walk-away automation approaches with personalized customer service to provide complete solutions for your laboratory.  Combining innovative engineering with high standards of quality, Agilent designs and manufactures high-performance equipment for processes that are revolutionizing pharmaceutical, biotech, and genomic research.